The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin–induced intestinal fluid secretion
Abstract
Secretory diarrhea is the leading cause of infant death in developing countries and a major cause of morbidity in adults. The cystic fibrosis transmembrane conductance regulator (CFTR) protein is required for fluid secretion in the intestine and airways and, when defective, causes the lethal genetic disease cystic fibrosis. We screened 50,000 chemically diverse compounds for inhibition of cAMP/flavone–stimulated Cl– transport in epithelial cells expressing CFTR. Six CFTR inhibitors of the 2-thioxo-4-thiazolidinone chemical class were identified. The most potent compound discovered by screening of structural analogs, CFTRinh-172, reversibly inhibited CFTR short-circuit current in less than 2 minutes in a voltage-independent manner with KI approximately 300 nM. CFTRinh-172 was nontoxic at high concentrations in cell culture and mouse models. At concentrations fully inhibiting CFTR, CFTRinh-172 did not prevent elevation of cellular cAMP or inhibit non-CFTR Cl– channels, multidrug resistance protein-1 (MDR-1), ATP-sensitive K+ channels, or a series of other transporters. A single intraperitoneal injection of CFTRinh-172 (250 μg/kg) in mice reduced by more than 90% cholera toxin–induced fluid secretion in the small intestine over 6 hours. Thiazolidinone CFTR inhibitors may be useful in developing large-animal models of cystic fibrosis and in reducing intestinal fluid loss in cholera and other secretory diarrheas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Snyder, J. D., & MERSON, M. H. (1982) · PubMed · Cited by 858
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels*
Aguilar-Bryan, L., & Bryan, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.2.0361 · Cited by 698
Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins
Kimberg, D. V., Field, M., Johnson, J., Henderson, A., & Gershon, E. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106599 · Cited by 600
Genetic Analysis of Italian Patients with Congenital Hyperinsulinism of Infancy
Sogno Valin, P., Proverbio, M. C., Diceglie, C., Gessi, A., di Candia, S., Mariani, B., Zamproni, I., Mangano, E., Asselta, R., Battaglia, C., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000350827 · Cited by 552
Cystic Fibrosis Heterozygote Resistance to Cholera Toxin in the Cystic Fibrosis Mouse Model
Gabriel, S. E., Brigman, K. N., Koller, B. H., Boucher, R. C., & Stutts, M. J. (1994) · Science · doi:10.1126/science.7524148 · Cited by 482
Role of CFTR in Airway Disease
PILEWSKI, J. M., & FRIZZELL, R. A. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s215 · Cited by 447
Pathophysiology of Gene-Targeted Mouse Models for Cystic Fibrosis
GRUBB, B. R., & BOUCHER, R. C. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s193 · Cited by 410
Chemical probes for anion transporters of mammalian cell membranes
Cabantchik, Z. I., & Greger, R. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.4.c803 · Cited by 380
Sheppard, D. N., & Welsh, M. J. (1992) · The Journal of general physiology · doi:10.1085/jgp.100.4.573 · Cited by 322
Pharmacology of CFTR Chloride Channel Activity
SCHULTZ, B. D., SINGH, A. K., DEVOR, D. C., & BRIDGES, R. J. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s109 · Cited by 282
Chao, A. C., de Sauvage, F. J., Dong, Y. J., Wagner, J. A., Goeddel, D. V., & Gardner, P. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06355.x · Cited by 273
Mechanism and cellular applications of a green fluorescent protein-based halide sensor
Jayaraman, S., Haggie, P., Wachter, R. M., Remington, S. J., & Verkman, A. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6047 · Cited by 264
Self-citationAcute undifferentiated human diarrhea in the tropics
Gorbach, S. L., Banwell, J. G., Chatterjee, B. D., Jacobs, B., & Sack, R. B. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106560 · Cited by 222
Galietta, L. J. V., Springsteel, M. F., Eda, M., Niedzinski, E. J., By, K., Haddadin, M. J., Kurth, M. J., Nantz, M. H., & Verkman, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101892200 · Cited by 216
Self-citationCell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists
Galietta, L. V. J., Jayaraman, S., & Verkman, A. S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.5.c1734 · Cited by 213
Self-citationJayaraman, S., Joo, N. S., Reitz, B., Wine, J. J., & Verkman, A. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131087598 · Cited by 197
Self-citationMa, T., Vetrivel, L., Yang, H., Pedemonte, N., Zegarra-Moran, O., Galietta, L. J. V., & Verkman, A. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205932200 · Cited by 175
Self-citationNovel pore-lining residues in CFTR that govern permeation and open-channel block
McDonough, S., Davidson, N., Lester, H. A., & McCarty, N. A. (1994) · Neuron · doi:10.1016/0896-6273(94)90030-2 · Cited by 174
Rasola, A., Galietta, L. J. V., Gruenert, D. C., & Romeo, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42276-9 · Cited by 79
Self-citationCl? channel inhibition by glibenclamide is not specific for the CFTR-type Cl? channel
Rabe, A., Disser, J., & Fr�mter, E. (1995) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00373986 · Cited by 79
A novel plant-derived inhibitor of cAMP-mediated fluid and chloride secretion
Gabriel, S. E., Davenport, S. E., Steagall, R. J., Vimal, V., Carlson, T., & Rozhon, E. J. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.1.g58 · Cited by 74
Richardson, S. H., & Kuhn, R. E. (1986) · Infection and Immunity · doi:10.1128/iai.54.2.522-528.1986 · Cited by 18
Cited by
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
Targeting virulence: a new paradigm for antimicrobial therapy
Clatworthy, A. E., Pierson, E., & Hung, D. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.24 · Cited by 1,406
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Cao, D., Neuberger, T., Turnbull, A., Singh, A., Joubran, J., Hazlewood, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904709106 · Cited by 1,228
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
Jiang, H., He, H., Chen, Y., Huang, W., Cheng, J., Ye, J., Wang, A., Tao, J., Wang, C., Liu, Q., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171419 · Cited by 748
Mucus Clearance and Lung Function in Cystic Fibrosis with Hypertonic Saline
Donaldson, S. H., Bennett, W. D., Zeman, K. L., Knowles, M. R., Tarran, R., & Boucher, R. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043891 · Cited by 694
Metadata
- Authors
- Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J. V., & Verkman, A. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-12-01
- Volume
- 110
- Issue
- 11
- Pages
- 1651-1658
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4233502188
- Cited by
- 536
- References
- 22
- FWCI
- 14.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.